Purple Biotech Reports Q3 Basic And Diluted Loss Per ADS Of $0.39, Exits Quarter With Cash & Equivalents Worth $5.438M
Purple Biotech Reports Q3 Basic And Diluted Loss Per ADS Of $0.39, Exits Quarter With Cash & Equivalents Worth $5.438M
purple biotech發佈第三季度每ADS基本和稀釋虧損爲$0.39，季度末現金及等價物價值$5.438M
Purple Biotech Reports Q3 Basic And Diluted Loss Per ADS Of $0.39, Exits Quarter With Cash & Equivalents Worth $5.438M
Purple Biotech報告稱，第三季度每股ADS的基本虧損和攤薄虧損爲0.39美元，本季度退出時現金及等價物價值543.8萬美元
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間